texas oncology more breakthroughs. more victories

Share:

 
 

Dr. Houston Holmes Discusses CAR T Therapy Adoption and Education

By Laura Joszt

Publication: American Journal of Managed Care

Dr. Houston Holmes discusses the delivery of CAR-T therapies in a community setting at the Community Oncology Alliance’s (COA) 2018 Community Oncology Conference.

With chimeric antigen receptor (CAR) T-cell therapy being so new, there is going to be a learning curve as providers become more educated about the treatments, the manufacturing process, and the toxicities, Houston Holmes, MD, MBA, FACP, a medical oncologist with Texas Oncology, explained at the Community Oncology Alliance’s (COA) 2018 Community Oncology Conference.

Read the full story at American Journal of Managed Care.

Related Physicians

Related Cancer Centers